DE69304076D1 - N-cyano-n'-pyridylguanidine als serotoninantagonisten - Google Patents

N-cyano-n'-pyridylguanidine als serotoninantagonisten

Info

Publication number
DE69304076D1
DE69304076D1 DE69304076T DE69304076T DE69304076D1 DE 69304076 D1 DE69304076 D1 DE 69304076D1 DE 69304076 T DE69304076 T DE 69304076T DE 69304076 T DE69304076 T DE 69304076T DE 69304076 D1 DE69304076 D1 DE 69304076D1
Authority
DE
Germany
Prior art keywords
pct
stands
hydroxy
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69304076T
Other languages
English (en)
Other versions
DE69304076T2 (de
Inventor
Erik Bramm
Hans Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of DE69304076D1 publication Critical patent/DE69304076D1/de
Application granted granted Critical
Publication of DE69304076T2 publication Critical patent/DE69304076T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69304076T 1992-09-15 1993-09-13 N-cyano-n'-pyridylguanidine als serotoninantagonisten Expired - Lifetime DE69304076T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929219472A GB9219472D0 (en) 1992-09-15 1992-09-15 Chemical compounds
PCT/DK1993/000291 WO1994006770A1 (en) 1992-09-15 1993-09-13 N-cyano-n'-pyridylguanidines as serotonin antagonists

Publications (2)

Publication Number Publication Date
DE69304076D1 true DE69304076D1 (de) 1996-09-19
DE69304076T2 DE69304076T2 (de) 1997-04-03

Family

ID=10721912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69304076T Expired - Lifetime DE69304076T2 (de) 1992-09-15 1993-09-13 N-cyano-n'-pyridylguanidine als serotoninantagonisten

Country Status (16)

Country Link
US (1) US5563160A (de)
EP (1) EP0660823B1 (de)
JP (1) JP3485567B2 (de)
KR (1) KR100292592B1 (de)
AT (1) ATE141262T1 (de)
AU (1) AU670816B2 (de)
CA (1) CA2143756C (de)
DE (1) DE69304076T2 (de)
DK (1) DK0660823T3 (de)
ES (1) ES2092835T3 (de)
FI (1) FI109118B (de)
GB (1) GB9219472D0 (de)
GR (1) GR3021015T3 (de)
NZ (1) NZ255330A (de)
RU (1) RU2141951C1 (de)
WO (1) WO1994006770A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696140A (en) * 1992-09-15 1997-12-09 Leo Pharmaceutical Products Ltd. N-cyano-N'-pyridylguanidines as serotonin antagonists
US5869497A (en) * 1996-03-15 1999-02-09 Eli Lilly And Company Method of treating or ameliorating the symptoms of common cold or allergic rhinitis
EP0795328A1 (de) * 1996-03-15 1997-09-17 Pfizer Inc. Verwendung von Naphthalenderivate zur Behandlung von Lungenkrebs
GB9711126D0 (en) 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Cyanoamidines
GB9711127D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
GB9711124D0 (en) 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
GB9711119D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
GB9711122D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
GB9711123D0 (en) 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
GB9711125D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
CA2335038A1 (en) * 1998-06-15 1999-12-23 Arch Development Corporation Combination of radiotherapy and anti-angiogenic factors
AU4080300A (en) * 1999-04-09 2000-11-14 Shionogi Bioresearch Corp. Cyanoguanidine compounds
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
AU1494702A (en) 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
BR0209930A (pt) * 2001-05-24 2004-03-30 Leo Pharma As Composto, composição farmacêutica, método para tratar doenças proliferativas, e, uso de um composto
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
JP4935073B2 (ja) 2003-10-14 2012-05-23 味の素株式会社 エーテル誘導体
DE102004008141A1 (de) * 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
JP5189367B2 (ja) 2004-12-22 2013-04-24 レオ ファーマ アクティーゼルスカブ 新規シアノグアニジン化合物
WO2007022964A2 (de) 2005-08-24 2007-03-01 Abbott Gmbh & Co. Kg Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
EP2197443A4 (de) 2007-09-26 2014-01-01 Gemin X Pharmaceuticals Canada Inc Zusammensetzungen und verfahren zur herbeiführung von nad+-spiegeln mithilfe eines nicotinamid-phosphoribosyl-transferase-hemmers
US8173677B2 (en) 2007-09-26 2012-05-08 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
AU2010210248B2 (en) 2009-02-06 2012-08-16 Tianjin Hemay Bio-Tech Co., Ltd. Pharmaceutical compositions comprising pyridyl cyanoguanidine, process for preparing the same and use thereof
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
KR20140020823A (ko) * 2010-09-03 2014-02-19 포르마 티엠, 엘엘씨. Ｎａｍｐｔ의 억제를 위한 구아니딘 화합물 및 조성물
WO2012055346A1 (zh) 2010-10-26 2012-05-03 天津和美生物技术有限公司 N-(6-(4-氯苯氧基)己基)-n'-氰基-n''-(4-吡啶基)胍的多晶型物及其制备和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators

Also Published As

Publication number Publication date
WO1994006770A1 (en) 1994-03-31
AU670816B2 (en) 1996-08-01
JPH08501539A (ja) 1996-02-20
CA2143756C (en) 2003-11-11
JP3485567B2 (ja) 2004-01-13
EP0660823A1 (de) 1995-07-05
RU2141951C1 (ru) 1999-11-27
ATE141262T1 (de) 1996-08-15
DK0660823T3 (da) 1996-09-23
EP0660823B1 (de) 1996-08-14
AU4945693A (en) 1994-04-12
FI951189A (fi) 1995-03-14
DE69304076T2 (de) 1997-04-03
US5563160A (en) 1996-10-08
GB9219472D0 (en) 1992-10-28
FI951189A0 (fi) 1995-03-14
KR950702964A (ko) 1995-08-23
GR3021015T3 (en) 1996-12-31
FI109118B (fi) 2002-05-31
CA2143756A1 (en) 1994-03-31
ES2092835T3 (es) 1996-12-01
NZ255330A (en) 1997-06-24
KR100292592B1 (ko) 2001-09-17
RU95105437A (ru) 1996-10-27

Similar Documents

Publication Publication Date Title
ATE141262T1 (de) N-cyano-n'-pyridylguanidine als serotoninantagonisten
DE69318854T2 (de) Spiroazacyclischderivate als substanz p antagonisten
NO982330D0 (no) Pyrazolderivater, fremgangsmÕte for fremstilling derav og farmas÷ytiske preparater inneholdende nevnte derivater
DE69739733D1 (de) 1-phenyl-benzimidazolverbindungen und ihre verwendung als modulatoren des gaba-a-rezeptors
BR9405910A (pt) Piridinas substituídas heterocíclicas herbicidas
ATE194836T1 (de) Benzimidazolverbindungen und ihre verwendung als modulatoren des gabaa-rezeptorkomplexes
ES2105617T3 (es) Derivados de piperacina como antagonistas de 5-ht.
ATE168102T1 (de) 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren
NO982778L (no) Morfinderivater med smertestillende virkning
BG103867A (en) Cyanoguanidines as cell proliferation inhibitors
ATE248819T1 (de) Cyanoguanidine als zellproliferation inhibitoren
DE69719974T2 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69319439T2 (de) Propensäure derivate verwendbar als fungizide
HUP0004590A2 (hu) Endotelin-antagonista imidazolszármazékokat és béta receptor blokkolókat tartalmazó kombinációs gyógyszerkészítmények
ATE191465T1 (de) Carbamoylcarbonsäureamide
NZ337749A (en) Benzimidazole derivative and their use in allergy-related disease
DE69620222D1 (de) Arylethanolaminderivate und deren verwendung als agonisten von atypischen beta-adrenorezeptoren
LV10960A (lv) Panemiens starpproduktu iegusanai
DK0651747T3 (da) Carbostyrilderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LEO PHARMA A/S ZWEITNAME: LEO PHARMACEUTICAL PRODU